Cargando…

HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation

Although the immune system provides protection from cancer by means of immunosurveillance, which serves a major function in eliminating cancer cells, it may also lead to cancer immunoediting, molding tumor immunogenicity. Cancer cells exploit several molecular mechanisms to thwart immune-mediated de...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rodríguez, Josefa A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649701/ https://www.ncbi.nlm.nih.gov/pubmed/29085437 http://dx.doi.org/10.3892/ol.2017.6784

Ejemplares similares

Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms
por: Sapoznik, Sivan, et al.
Publicado: (2012)

Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
por: Vanichapol, Thitinee, et al.
Publicado: (2018)

Acquired mechanisms of immune escape in cancer following immunotherapy
por: Bryan Iorgulescu, J., et al.
Publicado: (2018)

Immune escape mechanisms and immunotherapy of urothelial bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021)

Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy
por: Aktar, Nasrin, et al.
Publicado: (2022)

Benchmarking HLA genotyping and clarifying HLA impact on survival in tumor immunotherapy
por: Li, Xiangyong, et al.
Publicado: (2021)

The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture
por: Garrido, Federico, et al.
Publicado: (2017)

The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells
por: Liu, Lu, et al.
Publicado: (2020)

Towards Curative Cancer Immunotherapy: Overcoming Posttherapy Tumor Escape
por: Zhou, Gang, et al.
Publicado: (2012)

Immune escape and resistance to immunotherapy in mismatch repair deficient tumors
por: Mestrallet, Guillaume, et al.
Publicado: (2023)

Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
por: Angelova, Mihaela, et al.
Publicado: (2015)

Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms
por: D’Orsogna, Lloyd, et al.
Publicado: (2017)

Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors
por: Pan, Jenny H, et al.
Publicado: (2015)

Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope
por: Cole, David K., et al.
Publicado: (2017)

Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma
por: Fangazio, Marco, et al.
Publicado: (2021)

Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
por: He, Yunbo, et al.
Publicado: (2022)

CD47/SIRPα pathway mediates cancer immune escape and immunotherapy
por: Jia, Xiao, et al.
Publicado: (2021)

Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes
por: Gil-Julio, Hernani, et al.
Publicado: (2021)

The Evolutionary Selective Advantage of HIV-1 Escape Variants and the Contribution of Escape to the HLA-Associated Risk of AIDS Progression
por: Asquith, Becca
Publicado: (2008)

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?
por: Nijland, Marcel, et al.
Publicado: (2017)

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
por: McGranahan, Nicholas, et al.
Publicado: (2017)

Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
por: Yin, Shan-Shan, et al.
Publicado: (2020)

Microbial hydrogen “manufactory” for enhanced gas therapy and self-activated immunotherapy via reduced immune escape
por: Yan, Hongyu, et al.
Publicado: (2022)

Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipients
por: Crawford, Hayley, et al.
Publicado: (2009)

Revisiting immune escape in colorectal cancer in the era of immunotherapy
por: Ijsselsteijn, Marieke Erica, et al.
Publicado: (2019)

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
por: Pearson, Joshua R. D., et al.
Publicado: (2020)

Vías de escape
por: Greene, Graham, 1904-1991

The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
por: Leone, Kevin, et al.
Publicado: (2018)

Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma
por: Lee, Holly, et al.
Publicado: (2023)

HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success
por: Kanchan, Kanika, et al.
Publicado: (2022)

Do Tumor Mechanical Stresses Promote Cancer Immune Escape?
por: Onwudiwe, Killian, et al.
Publicado: (2022)

Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients
por: Montes, Paola, et al.
Publicado: (2018)

Opposing effects of immunotherapy in melanoma using multisubtype interferon-alpha – can tumor immune escape after immunotherapy accelerate disease progression?
por: Strannegård, Örjan, et al.
Publicado: (2015)

p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy
por: Lu, Chunwan, et al.
Publicado: (2020)

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
por: Erbe, Amy K., et al.
Publicado: (2017)

Improving the outcome of adoptive cell transfer by targeting tumor escape
por: Kaluza, Karen M., et al.
Publicado: (2013)

Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies
por: Stephan-Falkenau, Susann, et al.
Publicado: (2023)

Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
por: Litchfield, Kevin, et al.
Publicado: (2020)

B lymphocytes may escape tolerance by revising their antigen receptors
Publicado: (1993)

Critical effect of Pol escape mutations associated with detrimental allele HLA-C(∗)15:05 on clinical outcome in HIV-1 subtype A/E infection
por: Murakoshi, Hayato, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mc9jd2t6gvud5ber8s661ilcs5